T 1427/14 (GLP-2 analogues/ZEALAND) of 15.11.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T142714.20181115
- Date of decision
- 15 November 2018
- Case number
- T 1427/14
- Petition for review of
- -
- Application number
- 06727006.6
- IPC class
- A61K 38/26C07K 14/605
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Glucagon-like-peptide-2 (GLP-2) analogues
- Applicant name
- Zealand Pharma A/S
- Opponent name
- Shire - NPS Pharmaceuticals, Inc.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13
- Keywords
- Main request: inventive step (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent with the following claims and a description and drawings to be adapted thereto:
claims 1 to 27 of the main request, filed as auxiliary request 12 with the letter of 13 September 2018.